Combined treatment with mTORC1 inhibitor everolimus also showed similar effect (Supplementary Fig. 8e), suggesting that the enhancement of AMPK activity or inhibition of mTORC1 activity are potential strategies to enhance the antiproliferation of EGFR TKI in EGFRWT NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.